A recent KFF Health Tracking Poll found that affordability is a major barrier to access to GLP-1 medications, with more than half of adults who have taken the medications saying they had difficulty paying for them.
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.